Navigation Links
Spring Point Project Names New Members to Board of Directors
Date:6/16/2008

tly, there are about 25 million people in the United States with diabetes, representing approximately eight percent of the population. Diabetes alone represents 11 percent of the nation's health care expenditure.

Spring Point Project works in partnership with the Diabetes Institute for Immunology and Transplantation of the University of Minnesota on the mission to expedite the affordable and widespread availability of islet tissue to diabetes patients. In this partnership, the two organizations provide the science and the source needed to move toward a cure for diabetes. The Diabetes Institute conducts the preclinical and clinical trials, and Spring Point Project builds and operates the biosecure facilities where high-health source pig donors are developed.

The Diabetes Research and Wellness Foundation, a not-for-profit worldwide network based in Washington, D.C., is also part of the partnership with a major $6.2 million grant to Spring Point Project.

To contact Spring Point Project, visit http://www.SpringPointProject.org. To contact the Diabetes Institute for Immunology and Transplantation, visit http://www.diabetesinstitute.org. To contact Diabetes Research & Wellness Foundation, visit http://www.diabeteswellness.net.

Contact:

Molly Kersten

R/P Marketing Public Relations

(419)241-2221

mkersten@r-p.com


'/>"/>
SOURCE Spring Point Project
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
2. Creating the Bionic Woman: Making Nerves Spring Back to Life
3. Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply
4. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
5. MaxCyte to Present at BIO-Europe Spring 2008 Conference
6. Springer publishes anthology with the Nanoethics Group
7. eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008
8. SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008
9. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
10. CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference
11. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm ... quantification of partially hydrolyzed gluten in foods, has been accepted by AOAC International ... “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on ...
(Date:7/30/2015)... July 30, 2015 AACC welcomed thousands ... 2015 AACC Annual Meeting & Clinical Lab Expo ... 26–30. The meeting showcased revolutionary advancements in clinical ... of healthcare providers to diagnose patients quickly and ... treatment. As of Wednesday, July ...
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, ... as Sales & Marketing Director. , With more than 25 years of ... for reinforcing Tronics’ business development activities worldwide. He brings to the company his ...
(Date:7/30/2015)... VANCOUVER, Washington , July 30, 2015 ... "Biosimulation Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, ... (Drug Discovery & Development, Preclinical, Clinical Trial), by End ... the Biosimulation Market is expected to reach USD 2,107.99 ... at a CAGR of 15.29%. Browse ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4
... palm plantations will worsen the dual environmental crises of ... protected, warn scientists in the most comprehensive review of ... from the Zoological Society of London and University of ... the role of palm oil production in tropical deforestation ...
... Micromet, Inc.,(Nasdaq: MITI ) ("Micromet" or ... for the treatment of cancer,inflammation and autoimmune diseases, ... board of directors appointed Dr. Peter Johann, a,current ... member of the Company,s,audit committee. The appointment fills ...
... 15 Inverness Medical,Innovations, Inc. (Amex: IMA ), ... solutions, today declared a,dividend of $4.77 per share on ... dividend will be paid in shares of Series B,stock ... of (a) $4.77 divided by,(b) 97% of the average ...
Cached Biology Technology:Oil palm plantations are no substitute for tropical rainforests, a new study shows 2Oil palm plantations are no substitute for tropical rainforests, a new study shows 3Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule 2Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule 3Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule 4Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 2
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 To ... biometric security provider HYPR Corp. announced today the addition of ... will serve as board advisor and David Raviv ... to the team underscore HYPR Corp.,s commitment to providing the ... , Dimitri Sirota co-founded Layer 7 Technologies, a ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical contract manufacturing ... headquartered in Springville, Utah , has announced ... corporation with locations in Santa Clara, CA ... ). This acquisition will incorporate MedConx,s manufacturing facility ... existing facility in Costa Rica , resulting ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... States stem from bat bites, far more people are treated ... most often reported rabid mammal. Controlling the spread of rabies ... where new outbreaks might occur and how the virus might ... journal PLoS Biology, Real and colleagues apply a mathematical model ...
... isn't very clear, especially when it comes to the vaccine ... end if you want to understand what the vaccine is ... 16, 2005 -- The European Vaccine Effort against HIV/AIDS today ... vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV ...
... Environmental Microbiology reveals that indigenous microbiota of the ... oil. Scientists from the Estación Experimental del Zaidín ... in situ crude oil degradation after the Prestige ... spill, hydrocarbons are subjected to physicochemical processes such ...
Cached Biology News:Rabies spread speeds up 2'EuroVacc 02' HIV Vaccine Trial Begins 2'EuroVacc 02' HIV Vaccine Trial Begins 3A hope for oil spill bioremediation 2
Mouse Wnt-9b Biotinylated Affinity Purified PAb ENTREZ GeneID: 22412...
Biotin anti-human CD164...
Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
... Ready-to-use liquid controls for monitoring Aldolase ... & abnormal) with targeted manufacturing values ... 20 ± 3 IU/L. 30-day ... at 2-8 C. Level 1: 3 ...
Biology Products: